Connexin hemichannel induced vascular leak suggests a new paradigm for cancer therapy (Q38189165)

30 August 2017

Connexin hemichannel induced vascular leak suggests a new paradigm for cancer therapy (English)

1 reference

30 August 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24548560%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

2

Simon J O'Carroll

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24548560%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Kimiora Henare

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24548560%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Louise Nicholson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24548560%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Colin Green

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24548560%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Lai-Ming Ching

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24548560%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Susan Ormonde

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24548560%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Helen V Danesh-Meyer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24548560%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

English

0 references

publication date

15 February 2014

1 reference

30 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24548560%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

588

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24548560%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24548560%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

1365-1371

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24548560%20AND%20SRC:MED&resulttype=core&format=json

Tumor angiogenesis: therapeutic implications

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Notch and VEGF pathways play distinct but complementary roles in tumor angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Hypoxia and defective apoptosis drive genomic instability and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Influence of tumour micro-environment heterogeneity on therapeutic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Anti-angiogenic therapy: concept to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Side effects of anti-angiogenic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Time course of imaging changes of GBM during extended bevacizumab treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Blocking connexin43 expression reduces inflammation and improves functional recovery after spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Connexin43 antisense oligodeoxynucleotide treatment down-regulates the inflammatory response in an in vitro interphase organotypic culture model of optic nerve ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Silencing the expression of connexin 43 decreases inflammation and joint destruction in experimental arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Importance of Connexin-43 based gap junction in cirrhosis and acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Ischemia-induced brain damage depends on specific gap-junctional coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Gap-junction-mediated propagation and amplification of cell injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Effective reduction of infarct volume by gap junction blockade in a rodent model of stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Limiting burn extension by transient inhibition of Connexin43 expression at the site of injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Targeting connexin43 expression accelerates the rate of wound repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Patterns of gene expression reveal a temporally orchestrated wound healing response in the injured spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Improved corneal wound healing through modulation of gap junction communication using connexin43-specific antisense oligodeoxynucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Roles of connexins in atherosclerosis and ischemia-reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Connexin channel-dependent signaling pathways in inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Cell-cell interactions: leukocyte-endothelial interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Gap junctions and connexin-mediated communication in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Connexin43 modulates neutrophil recruitment to the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Bacteremic sepsis disturbs alveolar perfusion distribution in the lungs of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Impairment of functional capillary density but not oxygen delivery in the hamster window chamber during severe experimental malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Cerebral microvascular pathology in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Vascular degeneration in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Neuroinflammatory processes in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Injury of skeletal muscle and specific cytokines induce the expression of gap junction channels in mouse dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Connexin channels provide a target to manipulate brain endothelial calcium dynamics and blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Blood-brain barrier breakdown after embolic stroke in rats occurs without ultrastructural evidence for disrupting tight junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Pathogenetic aspects of the glaucomatous optic neuropathy: fluorescein angiographic findings in patients with primary open angle glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Correlation between a disc hemorrhage and peripapillary atrophy in glaucoma patients with a unilateral disc hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Disc haemorrhage and glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

The role of glia in retinal vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Age-Related Macular Degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Effects of ischemic preconditioning and bevacizumab on apoptosis and vascular permeability following retinal ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Blood-retinal barrier breakdown following experimental retinal ischemia and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Physiological role of gap-junctional hemichannels. Extracellular calcium-dependent isosmotic volume regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Role of the VEGF/VEGFR axis in cancer biology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Regulation of connexin43 gap junction protein triggers vascular recovery and healing in human ocular persistent epithelial defect wounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Connexin 43 mimetic peptides reduce swelling, astrogliosis, and neuronal cell death after spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Chromenes: potential new chemotherapeutic agents for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Impact of tumor hypoxia and anemia on radiation therapy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Pannexin: from discovery to bedside in 11±4 years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Connexin and pannexin hemichannels in inflammatory responses of glia and neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Expression of pannexin isoforms in the systemic murine arterial network

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Intercellular redistribution of cAMP underlies selective suppression of cancer cell growth by connexin26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Endothelial connexin32 enhances angiogenesis by positively regulating tube formation and cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.02.003

10.1016/J.FEBSLET.2014.02.003

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24548560%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference